ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL HEART, LUNG, AND BLOOD INSTITUTE

Discovery and interrogation of genetic regulatory variation impacting Atrial Fibrillation risk

Completed
Institution
University of Chicago, IL
Principal investigator
Ivan Paul Moskowitz
Funding
$772K
Duration
2022–2026
Open portfolio

Moonbase score

Still being scored

Abstract

Abstract The overall goal of this multi-principal investigator proposal is to facilitate the transition from implication of genetic variants identified in extensive genome wide association studies (GWAS) of Atrial Fibrillation (AF) to the molecular mechanisms underlying AF risk. We hypothesize that a novel genomic and analytic pipeline interrogating regulatory function of genetic variation will identify candidate causative variants and their target genes, enabling the transition from simple associations to causative mechanisms for the arrhythmia. In preliminary studies, we have applied novel single cell approaches to generate cell-type-resolved high-resolution chromosome accessibility maps and taken advantage of coordinated genomic signals to link AF risk variants to candidate causative AF genes. The results describe a highly interconnected gene regulatory network for cardiac atrial gene expression. In our first aim we propose to generate multi-modal single-cell genomics data to provide higher-resolution annotation of variant effects. We will improve our computational procedure to better leverage these datasets for AF variant and gene discovery. In our second aim, we will interrogate the interconnected gene regulatory network in molecular enhancer assays and genomic chromatin conformation capture experiments, to directly examine the impact of nominated genetic variants and their physical association with candidate target genes. In our third aim, we will examine the functionality of high confidence variant SNPs in depth, including their impact on gene regulation in cis, their impact on human cardiomyocyte electrophysiology, and their impact on cardiomyocyte gene expression and chromatin status in trans. We have established a tractable strategy that will help enable the transition from AF risk variants to molecular mechanisms. We anticipate that our approach will help translate the promise of AF genetics into meaningful biological insights for AF and establish a paradigm for the molecular understanding of genetic association studies in any system.

Research team

  • Xin HePI
  • Ivan Paul MoskowitzPI
  • Sebastian PottPI

LOADING MOONBASE SCORE

NATIONAL HEART, LUNG, AND BLOOD INSTITUTER01Genetics of Health and Disease Study Section[GHD]cardiomyocytevariantsatrial fibrillationregulatory networkcausativeatrialrisk variantsfibrillation

Questions for University of Chicago

Answered by the team behind this research.

Same researchers, same institution, same topic, scored first.